CALL/MERCK & CO./150/0.1/17.01.25 | Market Closed - BOERSE MUENCHEN 19:26:26 06/06/2024 BST | ||
| 0.188 EUR | -1.05% |
|
| Current month | +27.03% | ||
| 1 month | +2.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 06/06/24 | 0.188 | -1.05% |
| 05/06/24 | 0.19 | -3.55% |
| 04/06/24 | 0.197 | +9.44% |
| 03/06/24 | 0.18 | +21.62% |
| 31/05/24 | 0.148 | -11.38% |
Real-time BOERSE MUENCHEN
Last update June 06, 2024 at 07:26 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GZ7P4R |
| ISIN | DE000GZ7P4R0 |
| Date issued | 25/01/2023 |
| Strike | 150 $ |
| Maturity | 17/01/2025 (225 Days) |
| Parity | 10 : 1 |
| Emission price | 0.28 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.54 € |
|---|---|
| Lowest since issue | 0.031 € |
| Spread | 0.02 € |
| Spread % | 9.09% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.5
USD
Average target price
142.7
USD
Spread / Average Target
+9.32%
- Stock Market
- Warrants
- Warrant